← All peptidesGLP-1 / Metabolic
Retatrutide
Triple agonist (GIP/GLP-1/glucagon). Phase 3 trials show superior weight loss.
Typical dose
2–12 mg
Frequency
Once weekly
Half-life
—
Route
subcutaneous
Typical vial sizes
10 mg20 mg30 mg
Sample reconstitution
10 mg vial · 2 mL bac water · 7 mg dose
- Draw volume
- 1.400 mL
- Insulin units
- 140 units
- Concentration
- 5.00 mg/mL
- Doses per vial
- 1.4
Research notes
Investigational. Strongest fat loss results in clinical trials so far.
Research use only.
Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.